Silica dust worsens asthma inflammation and blocks steroid treatment, study finds

A team of researchers at the University of Sharjah has identified a mechanism that may explain why some asthma patients struggle to respond to the drugs that typically control their disease. In laboratory experiments using mice and human airway cells, they found that exposure to crystalline silica—a mineral dust common in certain workplaces and desert environments—can trigger a cascade of changes that leaves the lungs unable to respond properly to corticosteroids, the most widely prescribed asthma medications.

The study, published in the journal Allergy, exposed mice to crystalline silica, house dust mite allergens, or both in combination. When the animals encountered both substances together, the results were severe. Their airways narrowed, the walls thickened, and mucus accumulated. The inflammation was substantially worse than what occurred from dust mite exposure alone. Rabih Halwani, a professor of immunology at the University of Sharjah and co-author of the work, described the affected lungs as showing narrowed airways, accumulation of inflammatory cells, thickened airway walls, and increased mucus production. The mice also developed impaired lung function and a mixed immune response involving two types of inflammatory cells—eosinophils and neutrophils.

What made the findings particularly striking was what happened when the researchers administered dexamethasone, a potent corticosteroid. The drug failed to adequately control the inflammation and other changes in the silica-exposed animals. This suggested that silica exposure was not simply making asthma worse—it was actively undermining the treatment itself. The researchers traced this problem to the glucocorticoid receptor, the cellular protein through which steroids exert their anti-inflammatory effects. In normal lungs, the active form of this receptor, called GRα, predominates. But in silica-exposed lungs, GRα was nearly absent, while GRβ, a form that can interfere with steroid activity, was increased. The result was lung tissue that could no longer respond normally to corticosteroid treatment.

The mechanism behind this shift pointed to a cellular defense pathway called STING, which normally detects signs of damage or infection and triggers an immune response. In the silica-exposed lungs, STING and its associated signaling proteins were strongly activated. Dexamethasone failed to suppress this excessive activation, suggesting that the silica had hijacked a fundamental immune mechanism in a way that steroids could not counteract. Halwani explained that while STING activation is normally protective, excessive activation may contribute to persistent and harmful inflammation that resists conventional treatment.

The findings carry weight because they may offer an explanation for a clinical puzzle: why some asthma patients develop severe inflammation and simultaneously become resistant to the drugs designed to control it. Globally, asthma affects an estimated 363 million people and caused approximately 442,000 deaths in 2023, according to the World Health Organization. A subset of patients with severe asthma responds poorly to therapy, leaving them at greater risk of persistent symptoms, worsening lung function, and potentially life-threatening attacks. Growing evidence suggests that environmental exposures play an important role in this reduced responsiveness.

The researchers emphasize that their work remains preliminary. The experiments were conducted in mice and human airway cells in the laboratory, not in living human patients. They caution that rigorous clinical testing must occur before any potential application in humans can be considered. However, they describe the study as novel—to their knowledge, the first to demonstrate that the combination of crystalline silica and house dust mite allergens drives steroid hyporesponsiveness. The findings raise the possibility that targeting the STING pathway could provide a new therapeutic strategy for patients whose asthma responds poorly to corticosteroids, though the authors stress that additional studies, including experiments involving genetic deletion of STING, are needed before this can be confirmed.

The implications extend beyond asthma treatment. If confirmed in human studies, the findings could be particularly relevant to regions where populations are routinely exposed to desert dust storms or to workplaces where silica-containing particles are common—construction sites, mines, foundries, and manufacturing facilities. The study highlights the growing global burden of environmental and occupational silica exposure and argues that a better understanding of the underlying biological mechanisms is essential for both public health planning and clinical practice. Halwani concluded that by connecting silica-induced damage with persistent STING activation and reduced steroid responsiveness, the study provides a possible biological explanation for why allergic airway inflammation may become harder to control in high-dust environments.